Ex-CDC Director Redfield Warns Current Ebola Outbreak Could Spark Global Pandemic

Former CDC director Robert Redfield has issued a stark warning that the current Ebola outbreak in Central Africa could ignite a new global pandemic. Speaking recently on NewsNation's Elizabeth Vargas Report, Redfield stated he suspects this situation will evolve into a very significant pandemic. He explained that the outbreak is a major public health concern primarily because it was not recognized quickly enough.

Redfield noted that during his tenure as CDC director, he managed three previous Ebola outbreaks in the Democratic Republic of Congo. Typically, those incidents were identified after only five or ten cases. This current crisis, however, went unnoticed until there were over a hundred cases, and it has since surged past six hundred suspected infections with nearly 150 deaths.

Last week, the World Health Organization officially declared the situation in the Democratic Republic of Congo and Uganda a public health emergency of international concern. Health officials in both nations have reported 536 suspected cases, 105 probable cases, and 34 confirmed cases to date. These figures include 134 suspected deaths from the disease.

One American medical worker, Dr. Peter Stafford, tested positive for the virus while working in the Democratic Republic of Congo. He was flown to Germany for treatment after becoming sick just days after operating on a patient with severe abdominal pain. The first recorded case in this outbreak occurred on April 24 involving a health worker in Bunia who suffered from fever, hemorrhaging, and vomiting before dying.

It took three weeks for tests to confirm the worker's infection, a delay that allowed the disease to spread further. Unlike influenza or COVID-19, Ebola does not transmit through the air but requires direct contact with the bodily fluids of an infected or deceased person. Approximately fifty percent of people infected with the current strain of the virus die from the disease.

In response to the threat, the US government announced that all Americans returning from high-risk nations must now travel to Dulles International Airport for screening. This rule applies to anyone who was in South Sudan, Uganda, or the Democratic Republic of Congo within the previous 21 days. Redfield expressed surprise that more than six hundred suspected cases were detected in a single outbreak, noting such numbers are highly unusual.

Travel disruptions have also occurred recently as a flight from Paris to Detroit was diverted to Montreal. Officials found a passenger from the Ebola-hit Democratic Republic of Congo on board. The individual disembarked in Montreal, underwent assessment by a quarantine officer, and was deemed asymptomatic before flying back to France. Canada's health agency confirmed the passenger had now returned to France safely.

The United States has confirmed that no travelers have tested positive for the virus despite ongoing concerns in the region.

Currently, the State Department maintains a Level 4 travel alert for the Democratic Republic of Congo, citing dangers from crime, unrest, terrorism, and health crises.

An American embassy official warned that the US government cannot provide emergency services to its citizens in the Ituri province.

Consequently, the embassy issued a strict directive stating that no one should travel to this specific area for any reason whatsoever.

Ituri province serves as the epicenter of the current outbreak, where the rare Bundibugyo strain of Ebola is spreading rapidly.

WHO Director-General Tedros Adhanom Ghebreyesus expressed deep concern regarding the scale and speed of this epidemic.

He noted that the virus carries a mortality rate of up to 50 percent and expects case numbers to rise significantly in the coming weeks.

While the risk of spread remains high within the DRC, South Sudan, and Uganda, the Director-General stated the global risk level is currently low.

Workers in full protective gear are shown attending to the coffin of a patient who died from the disease in the DRC.

Other images depict a worker spraying a building in the DRC to mitigate the spread of the outbreak among the local population.

CDC officials emphasized that the risk to the general US public remains low but urged travelers to avoid the affected areas entirely.

They also advised anyone visiting the region to monitor for symptoms for 21 days after leaving the Democratic Republic of Congo.

Although specific screening details for the upcoming World Cup were not released, the CDC stated it is actively collaborating with FIFA.

The agency aims to ensure safe passage for all attendees and to keep the American public safe throughout the entire competition.

To support these efforts, the CDC is deploying personnel to the DRC and Uganda alongside essential protective equipment and resources.

These teams will provide direct technical assistance focused on aggressive disease tracking and comprehensive contact tracing operations.

Dr. Anne Ancia, head of the WHO team in the DRC, revealed that the first suspected case was a health worker showing symptoms on April 24.

However, she clarified that patient zero has not yet been identified by the international health organization.

This marks the 17th Ebola outbreak in the DRC since the virus was discovered in 1976, though it is only the third involving the Bundibugyo strain.

Previous outbreaks of this specific strain occurred in 2007 and 2012, while the 2018 and 2020 events each claimed over 1,000 lives.

The largest outbreak in history took place between 2014 and 2016 in West Africa, where more than 28,600 cases were reported globally.

Common symptoms include fever, headache, muscle pain, weakness, diarrhea, vomiting, abdominal pain, and unexplained bleeding or bruising.

The mortality rate for the Bundibugyo virus specifically ranges between 25 and 50 percent according to current data.

The Zaire strain, which is the most common form of Ebola, can be treated with drugs like Inmazeb and Ebanga.

Additionally, the Ervebo vaccine is available for use only during active outbreaks to manage the spread of the disease.

Dr. Ancia mentioned that officials are considering using the Ervebo vaccine but noted that any new approval would take months to become available.

She added that she does not see a possibility of ending this outbreak within the next two months given the current trajectory.